Search results
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 15 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 22 hours agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ expectations ...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 1 day agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with ...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 22 hours agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 19 hours agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks via Yahoo Finance· 2 days agoInvestors are always looking for stocks that are poised to beat at earnings season and Moderna, Inc....
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 14 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 2 days agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post ...